Keith Alcorn

Keith joined NAM’s staff team in 1991 and was our Senior Editor until 2018. He currently contributes news and conference reporting to aidsmap.com and edits infohep.org, our website covering hepatitis treatment news.

Cardiovascular disease

High rate of new peripheral artery disease cases in people with HIV

Cardiovascular disease

Integrase inhibitors raise the risk of heart attack, stroke during first two years of treatment

Child developmental issues

HIV-exposed children experience subtle delays in acquiring language and motor skills, review finds

Resistance

Dolutegravir resistance showing up after prolonged periods on failing treatment

Diabetes

Obesity more important than integrase inhibitors in risk for developing diabetes in people with HIV

HIV treatment for children & young people

High levels of infant resistance to abacavir and tenofovir in Namibia

Coronavirus

Canadian study finds minimal evidence of weaker COVID-19 vaccine responses in people with HIV

Elimination of hepatitis C

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV

Coronavirus

COVID-19 vaccines in people with HIV

Elimination of hepatitis C

UK report urges re-think on hepatitis C reinfection

Cancer

Low CD4/CD8 ratio predicts increased cancer risk in people with HIV

Coronavirus

CoronaVac shows weaker response in people with HIV

Liver disease

Fatty liver disease raises the risk of cardiovascular disease in people with HIV

Coronavirus

COVID-19 and coronavirus in people living with HIV

Cardiovascular disease

People with HIV more likely to develop high blood pressure after starting an integrase inhibitor

Liver disease

Metabolic disorders cause liver damage in people with HIV more often than viral hepatitis in lower-income countries

Coronavirus

Long COVID more common in people with HIV

Changing treatment

Further evidence that recycling tenofovir in second-line treatment is effective